The effect of adjuvant aromatase inhibitors on BMD in women with breast cancer
How to Cite
OrthoEvidence. The effect of adjuvant aromatase inhibitors on BMD in women with breast cancer. ACE Report. 2020;9(8):14. Available from: https://myorthoevidence.com/AceReport/Report/6307
Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trialLancet Oncol. 2014 Apr;15(4):474-82. doi: 10.1016/S1470-2045(14)70035-X. Epub 2014 Mar 11
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Four hundred and ninety-seven postmenopausal women with hormone-receptor-positive breast cancer were randomized to receive adjuvant exemestane 25 mg or anastrozole 1 mg daily for 5 years. Two subgroups were identified: those with baseline T-scores of -2.0 or greater at the spine and hip (subgroup 1), and those with baseline T-scores less than -2.0 at the spine and hip and taking bisphosphonates (s...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE